PresVu is a specialized prescription eye drop developed by Entod Pharmaceuticals, aimed at reducing the reliance on reading glasses for individuals suffering from presbyopia. This condition typically affects people around the age of 40, as it gradually diminishes the eye's ability to focus on close objects.
The active compound in PresVu is pilocarpine, which functions by contracting the iris muscles to control the pupil's size. This mechanism enhances the eye's ability to focus on nearby objects, thus minimizing the necessity for reading glasses. Additionally, PresVu incorporates an advanced dynamic buffer technology that adapts to the pH levels of tears, ensuring consistent efficacy.
According to medical professionals, the effects of PresVu typically span between four to six hours. While it does not serve as a permanent solution, it offers temporary relief from the need for reading glasses.
Some common side effects associated with PresVu include itching, redness, eyebrow pain, and muscle spasms in the eyes. It is important to note that it is not suitable for individuals with inflammation of the iris.
While pilocarpine has been a part of eye care treatments for decades, its use in treating presbyopia is a relatively recent development. In 2021, the U.S. FDA approved pilocarpine for presbyopia, with PresVu utilizing a 1.25% concentration for this purpose.
Kutos : AI Assistant!
